Intel Collaborated with QuTech to Develop 2-Qubit Silicon Quantum Chip

Intel Collaborated with Qutech to Develop 2-Qubit Silicon Quantum Chip

QuTech, Dutch quantum computer research company announced collaboration with Intel on February 21, 2018 to reveal first-ever programmable two-qubit quantum processor on silicon chips
Through this partnership, the companies will be offering breakthrough in large and extensive calculations. The qubits can be controlled by electronic signals. Silicon is used due to its property of causing less disruption. According to a blog post by QuTech, scientists performed the Deutsch-Josza algorithm on the new two-qubit quantum chip, which helps to determine odd or even function of device. The Grover-Search algorithm was also performed curates the right answer in one go from an unsorted set of options.

“In order to be able to execute more complex algorithms, we will develop silicon quantum chips with more qubits, both in the Delft cleanrooms and in industrial cleanrooms with our partner Intel,” said Lieven Vandersypen, Professor at QuTech. However, although it’s not the end product, it has applications in creating chips that can carry out scalable quantum calculations. Furthermore concept relies on two qubits, while a large combination is required to solving more complex and extensive calculations.
Furthermore, major market players are competing to develop chips with similar features. Microsoft had announced plans to develop quantum computing ecosystem in near future in September 2017.

You may be interested

Medical Cannabis Market | Global Trends, and Forecast to 2025
Healthcare
Healthcare

Medical Cannabis Market | Global Trends, and Forecast to 2025

Albert R - April 21, 2018

Increasing approval of medicinal cannabis products and growing research and development activities in the medical cannabis market are expected to support the growth of the market. For…

Familial Amyloid Cardiomyopathy Treatment Market-Moving Towards a Brighter Future
Healthcare
Healthcare

Familial Amyloid Cardiomyopathy Treatment Market-Moving Towards a Brighter Future

Albert R - April 21, 2018

Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy…

3D Cell Culture Market To Witness Robust Expansion by 2024
Healthcare
Healthcare

3D Cell Culture Market To Witness Robust Expansion by 2024

Albert R - April 21, 2018

3D cell culture is group of biological cells that are allowed to grow in artificial media in all three dimensions. It is used in drug discovery and…

Most from this category